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Abstract
The rat mesenteric resistance arteries are densely innervated by adrenergic 
vasoconstrictor nerves, CGRPergic vasodilator nerves and nitric oxide-
containing nerves. Those nerves have axo-axonal interactions to modulate 
vascular nerve function and to regulate vascular tone. The present study 
focused on a possible transmitter, which is involved in axo-axonal trans-
mission of adrenergic nerves and CGRP nerves. When nicotine is applied in 
the rat perfused mesenteric artery, nicotine stimulates nicotinic α3β4 nic-
otinic acetylcholine receptors on adrenergic nerves. This stimulation leads 
to the release of proton from adrenergic nerves. Released proton activates 
transient receptor potential vanilloid-1 receptors on neighboring CGRP 
nerves and CGRP is released to cause vasodilation. The present findings 
would explain why CGRPergic nerves, which are capsaicin-sensitive sensory 
nerves, have efferent function in spite of being primary afferent nerves. 
Namely, efferent adrenergic nerves, which momentarily and constantly 
regulate the vascular tone, may send their information to the neighboring 
CGRPergic nerves. Proton may be used as the transmitter for axo-axonal 
transmission to counteract excess vasoconstriction as the efferent function 
of afferent sensory nerves. Recent study demonstrated that periarterial 
nerve stimulation of perfused mesenteric arteries resulted in a decrease 
in the pH level of the perfusate concomitant with CGRPergic nerve-mediated 
vasodilation, which was abolished by the adrenergic neuron blocker, 
guanethidine. These findings suggest that proton acts as a transmitter for 
axo-axonal transmission between adrenergic and CGRPergic nerves in 
mesenteric resistance arteries. In conclusion, the present study presents 
evidence that perivascular nerves have strong axo-axonal interaction to 
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1. Introduction
It is widely accepted that the vascular tone is mainly 
maintained by sympathetic adrenergic nerves via the 
release of the neurotransmitter norepinephrine (NE). 
However, accumulating evidence reveals that non-
adrenergic, noncholinergic (NANC) vasodilator nerves 
play a role in the regulation of vascular tone. We have 
demonstrated that the rat mesenteric artery has dense 
innervation of calcitonin gene-related peptide (CGRP)-
containing (CGRPergic) nerves, which release a trans-
mitter CGRP to cause vasodilation [1]. Recently, we 
reported that nitric oxide (NO)-containing nerves in-
nervating rat mesenteric arteries are involved in mod-
ulation of adrenergic neurotransmission [2]. The rat 
mesenteric artery is also densely innervated by ad-
renergic nerves, which contain neuropeptide Y (NPY) 
with NE. Observations that double immunostainings 
in immunohistochemical study showed both NPY- and 
CGRP-immunoreactivities in the same neuron of the 
rat mesenteric artery [3] led to a hypothesis for the 
existence of some interactions between adrenergic 
nerves and CGRPergic nerves.
Our previous reports presented evidence that func-
tional deficiency of CGRPergic nerves augments ad-
renergic nerve-mediated vasoconstriction. Conversely, 
adrenergic nerves via NE release presynaptically in-
hibit the neurogenic release of CGRP from the nerve 
to decrease CGRPergic nerve function [4,5]. Thus, 
we have proposed that CGRPergic vasodilator nerves 
and sympathetic vasoconstrictor nerves reciprocally 
regulate the tone of the mesenteric resistance artery. 
Recently, we discovered a new axo-axonal interaction 
of perivascular adrenergic and CGRPergic nerves in 
the rat mesenteric artery [3,6,7]. Therefore, the pres-
ent study focused on a possible transmitter, which is 
involved in axo-axonal transmission of adrenergic 
nerves and CGRP nerves.
2. Reciprocal interaction between 
adrenergic nerves and NANC 
nerves
We reported that the rat mesenteric resistance ar-
tery has innervation of NANC vasodilator nerves in 
which CGRP, a potent vasodilator peptide, acts as 
a vasodilator neurotransmitter [1]. In rat perfused 
mesenteric vascular beds with active tone, the field 
stimulation of CGRPergic nerves, which contain CGRP, 
releases CGRP from the nerves to cause a potent va-
sodilation. Inhibition of CGRPergic function by cap-
saicin (CGRP depleting agent) and CGRP(8-37) (CGRP 
receptor antagonist) augmented adrenergic nerve-
mediated vaso constriction in response to field stim-
ulation, suggesting that CGRPergic nerves suppress 
sympathetic nerve-mediated vasoconstriction [4]. 
Conversely, CGRPergic nerve-mediated vasodilation 
was blunted by α2-adrenoceptor agonists (clonidine 
and NE) and NPY without affecting exogenous CGRP-
induced vaso dilation. This finding suggests that sym-
pathetic nerves presynaptically inhibit the release of 
CGRP from the nerve to decrease CGRPergic nerve 
function [5,8]. Thus, we have proposed that CGRPergic 
vasodilator nerves along with sympathetic vasocon-
strictor nerves reciprocally regulate the tone of the 
mesenteric resistance artery.
Immunohistochemical studies showed that the rat 
mesenteric arteries are densely innervated by NPY-like 
immunoreactive (LI) nerve fibers, which are eliminated 
by cold-storage denervation and 6-hydroxydopamine 
but not capsaicin. The CGRP-LI nerve fibers also densely 
innervate the mesenteric arteries and are abolished 
by cold-storage denervation and capsaicin but not 
6-hydroxydopamine [9], indicating that CGRPergic 
nerves are capsaicin-sensitive nerves. In additional 
studies, double immunostainings showed appearance 
of both NPY- and CGRP-LI nerve fibers in the same neu-
ron of the rat mesenteric artery [3]. These findings 
indicate that there are close contact areas between 
adrenergic and CGRPergic nerves and both nerves 
interact at these areas.
Our recent study demonstrated that L-NAME (NO 
synthase inhibitor) augments adrenergic nerve-
mediated vasoconstriction in rat mesenteric arteries 
without endothelium, and that augmented effect of 
L-NAME is reversed by L-arginine [2]. Additionally, 
L-NAME facilitates neurogenic release of NE from 
perivascular adrenergic nerves. Capsaicin abolishes 
L-NAME-induced augmentation of adrenergic nerve-
mediated vasoconstriction. However, L-NAME has no 
effect on CGRPergic nerve-mediated vasodilation. From 
these findings, we suggest that NO-containing nerves 
presynaptically regulate adrenergic neurotransmission 
by inhibiting transmitter NE release, but it is unlikely 
that the NO nerves directly cause vasodilation [2].
3. Axo-axonal interaction in vasodilation 
induced by nicotine and nicotinic 
acetylcholine receptor agonists
We have reported that, in rat perfused mesenteric vas-
cular beds with active tone and without endothelium, 
perfusion of nicotine and nicotinic acetylcholine (ACh) 
receptor agonists (cytisine and epibatidine) for 1 minute 
caused concentration-dependent vasodilation without 
inducing vasoconstriction [6,7]. The nicotine-induced 
vasodilation was abolished by cold-storage denerva-
tion, suggesting that perivascular nerves are responsi-
ble for the effect of nicotine. Additionally, vasodilation 
induced by nicotine and nicotinic ACh receptor ago-
nists was blunted by mecamylamine (α3β4 nicotinic ACh 
receptor antagonist), guanethidine (adrenergic neuron 
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blocker) and capsaicin, but not by α-bungarotoxin 
(α7 nicotinic ACh receptor antagonist) and dihydro-β-
erythroidine (α4β2 nicotinic ACh receptor antagonist). 
Therefore, it is very likely that intact adrenergic nerves 
and CGRPergic nerves mediate the nicotine- and nic-
otinic ACh receptor agonist-induced vasodilation [6,7]. 
Based on these results, it can be hypothesized that 
nicotine initially stimulates α3β4 nicotinic ACh recep-
tors, which are located on adrenergic nerves, to release 
adrenergic neurotransmitter(s) and related substances. 
These substances activate receptors located on ad-
jacent CGRP nerves and then release CGRP to cause 
vasodilation.
4. Transmitter(s) mediating nicotine-
induced vasodilation
To estimate possible substances transmitting nicotine-
induced vasodilation, several antagonists, which an-
tagonize the effect of adrenergic neurotransmitters, 
were used in additional studies. The nicotine-induced 
vasodilation was not inhibited by L-NAME (NO synthase 
inhibitor), propranolol (β-adrenoceptor antagonist), 
L-DOPA cyclohexyl ester (3,4-dihydroxyphenylalanine 
[DOPA] receptor antagonist), SCH23390 (selective 
dopamine D1 receptor antagonist), haloperidol (dopa-
mine D2 receptor antagonist), α,β-methylene ATP (ATP 
P2x receptor desensitizing agonist), 8(p-sulfo phenyl)
theophylline (adenosine A2 receptor antagonist) or 
BIBP3226 (NPY-Y1 receptor antagonist) [3]. Addition-
ally, perfusion of 3-methoxytyramine (COMT-metabolite 
of dopamine) and normetanephrine (COMT-metabolite 
of noradrenaline), but not other MAO- and COMT-
metabolites of dopamine and noradrenaline, induced 
concentration-dependent vasodilation in rat denuded 
mesenteric vascular beds. However, capsaicin treat-
ment, which abolished nicotine-induced vasodilation, 
did not affect vasodilation induced by both metabo-
lites. Therefore, it is unlikely that catecholamines, cate-
cholamine metabolites and other transmitters, which 
are released from perivascular adrenergic nerves, are 
involved in the nicotine-induced vasodilation.
5. Involvement of vanilloid-1 (transient 
receptor potential vanilloid-1; TRPV1) 
receptors in nicotine-induced 
vasodilation
Additional studies were focused on presynaptic re-
ceptors in CGRPergic nerves, since CGRPergic nerves 
are capsaicin-sensitive sensory nerves. It is well 
known that the primary sensory nerves are activated 
by acid and heat via vanilloid-1 (TRPV1) receptors. 
To estimate possible transmitter(s) for mediating the 
nicotine-induced vasodilation, we studied the effects 
of TRPV1 receptor antagonists on the nicotine-induced 
vasodilation. We have demonstrated that capsazepine 
(TRPV1 receptor antagonist) and ruthenium red (in-
hibitor of TRPV1 receptor response) concentration-
dependently inhibited the nicotine-induced vasodilation 
without affecting vasodilation in response to exoge-
nously applied CGRP [3]. Furthermore, immunohis-
tochemical staining of the mesenteric artery showed 
dense innervation of CGRP- and TRPV1-receptor-
immunopositive nerves, with both immunostainings 
appearing in the same neuron [3]. Therefore, these 
results strongly suggest that CGRPergic nerves inner-
vating mesenteric arteries have TRPV1 receptors and 
that TRPV1 receptors are involved in the nicotine-
induced vasodilation.
6. Proton as a possible transmitter for 
axo-axonal transmission
Based on our findings, it is possible to hypothesize 
that nicotine releases endogenous agonist for TRPV1 
receptors from adrenergic nerves. Since TRPV1 recep-
tors have been shown to be stimulated by proton, 
anandamide and lipid metabolites, we therefore fo-
cused on proton as an endogenous agonist for TRPV1 
receptors.
The additional studies were conducted to investi-
gate whether proton have a vascular effect in the per-
fused mesenteric vascular bed. Direct injection of 
HCl into the perfusate proximal to the denuded prep-
aration induced an initial sharp vasodilation followed 
by long-lasting vasodilation, while NaCl injection had no 
effect, suggesting that proton, but not chloride anion 
(Cl−), is responsible for the vasodilation. The HCl-
induced vasodilation was inhibited by capsazepine, 
ruthenium red, capsaicin and CGRP(8-37). Taken to-
gether, it is likely that proton (H+) induces vasodilation, 
which is associated with activation of TRPV1 receptors 
in the CGRP nerves.
To confirm further involvement of proton in the 
nicotine-induced vasodilation, we measured changes 
in the pH value of the perfusate, which had flowed 
out from the preparation and was continuously mon-
itored with a pH meter. The perfusion of nicotine 
caused a concentration-dependent decrease in pH 
values, which appeared during the vasodilation. The 
nicotine-induced pH reduction was abolished by 
mecamylamine and guanethidine, suggesting involve-
ment of proton (H+) in the nicotine-induced vasodi-
lation. These results clearly show that nicotine acts 
on presynaptic nicotinic α3β4 receptors in adrenergic 
nerves to release proton (H+) together with adrener-
gic neuro transmitter(s) or related substances and 
the released proton then stimulates TRPV1 receptors 
on CGRPergic nerves, resulting in CGRP release and 
vasodilation.
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7. Conclusions
The rat mesenteric resistance arteries are densely in-
nervated by adrenergic vasoconstrictor nerves, NANC 
CGRPergic vasodilator nerves and NO nerves. Those 
nerves have axo-axonal interactions to modulate the 
vascular nerve function and to regulate vascular tone. 
When nicotine is applied, nicotine stimulates nicotinic 
α3β4 nicotinic ACh receptors on adrenergic nerves. 
This stimulation leads to the release of proton from 
adrenergic nerves. Released proton activates TRPV1 
receptors on neighboring CGRP nerves, and CGRP is 
released and causes vasodilation. However, another 
process may be considered to explain this mecha-
nism. For example, it could be expected that released 
adrenergic transmitters, such as NE and ATP, may act 
on vascular smooth muscles to release proton or en-
dogenous TRPV1 agonists. These substances may stim-
ulate TRPV1 receptors in CGRPergic nerves. Another 
mechanism may explain that there are unknown 
nerves in the artery and released adrenergic transmit-
ters activate the unknown nerves, which can release 
proton to stimulate TRPV1. However, further study 
needs to be done to clarify these mechanisms.
The present findings would explain why CGRPergic 
nerves, which are capsaicin-sensitive sensory nerves, 
have efferent function in spite of being primary affer-
ent nerves. Namely, efferent adrenergic nerves, which 
momentarily and constantly regulate the vascular tone, 
may send their information via proton to the neigh-
boring CGRPergic nerves. This proton may be used as 
the transmitter for axo-axonal transmission to counter-
act excess vasoconstriction as the efferent function of 
afferent sensory nerves. We have reported interesting 
results that capsazepine and ruthenium red inhibited 
the CGRPergic nerve-mediated vasodilation in response 
to perivascular nerve stimulation of the mesenteric 
artery with intact adrenergic and CGRPergic nerves [3]. 
Furthermore, primary studies showed that periarterial 
nerve stimulation of perfused mesenteric arteries re-
sulted in decrease in the pH level of the perfusate 
concomitant with CGRPergic nerve-mediated vasodi-
lation. These findings also suggest that proton acts as 
a transmitter for axo-axonal transmission between 
adrenergic and CGRPergic nerves in mesenteric resis-
tance arteries.
In conclusion, the present study demonstrates evi-
dence that perivascular nerves have strong axo-axonal 
interaction to modulate nerve function and to regulate 
vascular tone.
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